Skip to main content

NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.

Publication ,  Journal Article
Vohra-Miller, S; Schwartz, IS
Published in: CMAJ
September 12, 2022

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

CMAJ

DOI

EISSN

1488-2329

Publication Date

September 12, 2022

Volume

194

Issue

35

Start / End Page

E1214

Location

Canada

Related Subject Headings

  • Viral Vaccines
  • SARS-CoV-2
  • Humans
  • General & Internal Medicine
  • COVID-19 Vaccines
  • COVID-19
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vohra-Miller, S., & Schwartz, I. S. (2022). NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ, 194(35), E1214. https://doi.org/10.1503/cmaj.220688
Vohra-Miller, Sabina, and Ilan S. Schwartz. “NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.CMAJ 194, no. 35 (September 12, 2022): E1214. https://doi.org/10.1503/cmaj.220688.
Vohra-Miller S, Schwartz IS. NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ. 2022 Sep 12;194(35):E1214.
Vohra-Miller, Sabina, and Ilan S. Schwartz. “NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection.CMAJ, vol. 194, no. 35, Sept. 2022, p. E1214. Pubmed, doi:10.1503/cmaj.220688.
Vohra-Miller S, Schwartz IS. NVX-CoV2373, a protein-based vaccine against SARS-CoV-2 infection. CMAJ. 2022 Sep 12;194(35):E1214.

Published In

CMAJ

DOI

EISSN

1488-2329

Publication Date

September 12, 2022

Volume

194

Issue

35

Start / End Page

E1214

Location

Canada

Related Subject Headings

  • Viral Vaccines
  • SARS-CoV-2
  • Humans
  • General & Internal Medicine
  • COVID-19 Vaccines
  • COVID-19
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences